Notably, however, patients receiving rituximab who were vaccinated 6–10 months after therapy showed a slightly ... from the Department of Medicine, Rheumatology and Clinical Immunology of ...

The notion that targeting TNF alone could be effective or economically viable as a long-term therapy for RA was greeted with incredulity and skepticism. Ultimately, it was the support of a Chief ...

A NEW Swedish study has found that menopausal hormone therapy (MHT) may be associated with an increased risk of developing ...

The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly increase with the use of menopausal hormone therapy, according to data published in Rheumatology.